Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies - Liqun Jiang, Aparna Pallavajjala, Jialing Huang, Lisa Haley, Laura Morsberger, Victoria Stinnett, Melanie Hardy, Rebecca Park, Candice Ament, Alexandra Finch, Alison Shane, Rebecca Parish, Azin Nozari, Patty Long, Emily Adams - Dissemin

Language
Login

Published in

Elsevier, The Journal of Molecular Diagnostics, 4(23), p. 467-483, 2021

DOI: 10.1016/j.jmoldx.2021.01.011

Links

Elsevier

Tools

Export citation

Search in Google Scholar

Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies

Journal article published in 2021 by Liqun Jiang, Aparna Pallavajjala, Jialing Huang, Lisa Haley

ORCID

, Laura Morsberger, Victoria Stinnett

ORCID

, Melanie Hardy, Rebecca Park, Candice Ament, Alexandra Finch, Alison Shane, Rebecca Parish, Azin Nozari, Patty Long

ORCID

ORCID

and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO